Jade Biosciences, Inc. (JBIO) Operating income 2020–2025
Jade Biosciences, Inc. (JBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$113.5MFY2025 · since FY2020: -$8.9M → -$113.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$113.5M | -52.2% |
| FY2024 | -$74.6M | +8.4% |
| FY2023 | -$81.4M | -52.9% |
| FY2022 | -$53.2M | -131.2% |
| FY2021 | -$23.0M | -159.0% |
| FY2020 | -$8.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JBIO financial trends
JBIO RevenueJBIO Net incomeJBIO Net marginJBIO Gross profitJBIO Gross marginJBIO Operating marginJBIO Operating cash flowJBIO Free cash flowJBIO Capital expendituresJBIO Return on equityJBIO Stock buybacksJBIO Dividends paidJBIO Total assetsJBIO Total liabilitiesJBIO Shareholders’ equityJBIO overview →